This week on the podcast Mikki speaks to Mike Murphy, Professor of Mitochondrial Redox Biology and co-creator of Mito Q, a coQ10 supplement that is specifically designed to target the mitochondria and offset free radical damage created through oxidative stress and improve health-related outcomes related to mitochondrial dysfunction. Of which there are many! Despite the science-based nature of the topic, Mike is great at distilling down information that we can all understand, and we discuss the latest research that links mitochondria to our health and wellbeing, and some tactics to help improve our cellular health.
Mike Murphy studied chemistry at Trinity College, Dublin
(1980-4) and obtained a PhD in Biochemistry from Peterhouse, University of Cambridge
(1984-7), carrying out research in the group of Martin Brand on mechanisms of mitochondrial proton pumping. Mike then carried out postdoctoral work at Columbia University (1988), followed by working as a VSO teacher in Zimbabawe (1989) and as a Lecturer in Biochemistry at Trinity College, Dublin (1990-2). He then moved to the Biochemistry Department at the University of Otago
, New Zealand (1992-2001), to set up his own research group, moving up to the level of Associate Professor. During this time he spent sabbatical visits in the lab of Jeff Schatz in Basel and that of Victor Darley-Usmar in Birmingham, Alabama. Mike joined the MRC MBU to establish an independent research group to study mitochondrial dysfunction in 2001. He was appointed an Honorary Fellow of the Royal Society of New Zealand
(Hon FRSNZ) in 2012 and was awarded the Keilin Memorial Lecture and Medal
in 2016. Mike has been a Wellcome Trust Investigator
since 2016. He was appointed Professor of Mitochondrial Redox Biology
(Cambridge University) in 2018. Mike was elected Fellow of the Academy of Medical Sciences
(FMedSci) in 2019.